Giugliani R - Search Results

1

Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data.

Giugliani R, Martins AM, Okuyama T, Eto Y, Sakai N, Nakamura K, Morimoto H, Minami K, Yamamoto T, Yamaoka M, Ikeda T, So S, Tanizawa K, Sonoda H, Schmidt M, Sato Y. Giugliani R, et al. Int J Mol Sci. 2021 Oct 10;22(20):10938. doi: 10.3390/ijms222010938. Int J Mol Sci. 2021. PMID: 34681597 Free PMC article.

2

Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression.

Munoz-Rojas MV, Vieira T, Costa R, Fagondes S, John A, Jardim LB, Vedolin LM, Raymundo M, Dickson PI, Kakkis E, Giugliani R. Munoz-Rojas MV, et al. Among authors: giugliani r. Am J Med Genet A. 2008 Oct 1;146A(19):2538-44. doi: 10.1002/ajmg.a.32294. Am J Med Genet A. 2008. PMID: 18792977

3

A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I.

Giugliani R, Rojas VM, Martins AM, Valadares ER, Clarke JT, Góes JE, Kakkis ED, Worden MA, Sidman M, Cox GF. Giugliani R, et al. Mol Genet Metab. 2009 Jan;96(1):13-9. doi: 10.1016/j.ymgme.2008.10.009. Epub 2008 Nov 26. Mol Genet Metab. 2009. PMID: 19038563 Clinical Trial.

4

[Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].

Giugliani R, Federhen A, Muñoz Rojas MV, Vieira TA, Artigalás O, Pinto LL, Azevedo AC, Acosta AX, Bomfim C, Lourenço CM, Kim CA, Horovitz D, Souza DB, Norato D, Marinho D, Palhares D, Santos ES, Ribeiro E, Valadares ER, Guarany F, De Lucca GR, Pimentel H, Souza IN, Corrêa Neto J, Fraga JC, Góes JE, Cabral JM, Simeonato J, Llerena JC Jr, Jardim LB, Giuliani Lde R, Silva LC, Santos M, Moreira MA, Kerstenetzky M, Ribeiro M, Ruas N, Barrios P, Aranda P, Honjo R, Boy R, Costa R, Souza CF, Alcântara FF, Avilla SG, Fagondes S, Martins AM. Giugliani R, et al. Rev Assoc Med Bras (1992). 2010 May-Jun;56(3):271-7. doi: 10.1590/s0104-42302010000300009. Rev Assoc Med Bras (1992). 2010. PMID: 20676532 Free article. Portuguese.

5

DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients; protective effect of enzyme replacement therapy.

Filippon L, Wayhs CA, Atik DM, Manfredini V, Herber S, Carvalho CG, Schwartz IV, Giugliani R, Vargas CR. Filippon L, et al. Among authors: giugliani r. Mutat Res. 2011 Apr 3;721(2):206-10. doi: 10.1016/j.mrgentox.2011.02.005. Epub 2011 Feb 18. Mutat Res. 2011. PMID: 21334454

6

Oxidative stress in patients with mucopolysaccharidosis type II before and during enzyme replacement therapy.

Filippon L, Vanzin CS, Biancini GB, Pereira IN, Manfredini V, Sitta A, Peralba Mdo C, Schwartz IV, Giugliani R, Vargas CR. Filippon L, et al. Among authors: giugliani r. Mol Genet Metab. 2011 Jun;103(2):121-7. doi: 10.1016/j.ymgme.2011.02.016. Epub 2011 Feb 26. Mol Genet Metab. 2011. PMID: 21420339

7

Recent Advances in Treatment Approaches of Mucopolysaccharidosis VI.

Giugliani R, Carvalho CG, Herber S, de Camargo Pinto LL. Giugliani R, et al. Curr Pharm Biotechnol. 2011 Jun;12(6):956-62. doi: 10.2174/138920111795542688. Curr Pharm Biotechnol. 2011. PMID: 21506914

8

Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment.

Giugliani R, Federhen A, Rojas MV, Vieira T, Artigalás O, Pinto LL, Azevedo AC, Acosta A, Bonfim C, Lourenço CM, Kim CA, Horovitz D, Bonfim D, Norato D, Marinho D, Palhares D, Santos ES, Ribeiro E, Valadares E, Guarany F, de Lucca GR, Pimentel H, de Souza IN, Correa J Sr, Fraga JC, Goes JE, Cabral JM, Simionato J, Llerena J Jr, Jardim L, Giuliani L, da Silva LC, Santos ML, Moreira MA, Kerstenetzky M, Ribeiro M, Ruas N, Barrios P, Aranda P, Honjo R, Boy R, Costa R, Souza C, Alcantara FF, Avilla SG, Fagondes S, Martins AM. Giugliani R, et al. Genet Mol Biol. 2010 Oct;33(4):589-604. doi: 10.1590/S1415-47572010005000093. Epub 2010 Dec 1. Genet Mol Biol. 2010. PMID: 21637564 Free PMC article.

9

Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP).

Hendriksz CJ, Giugliani R, Harmatz P, Lampe C, Martins AM, Pastores GM, Steiner RD, Leão Teles E, Valayannopoulos V; CSP Study Group. Hendriksz CJ, et al. Among authors: giugliani r. J Inherit Metab Dis. 2013 Mar;36(2):373-84. doi: 10.1007/s10545-011-9410-9. Epub 2011 Nov 30. J Inherit Metab Dis. 2013. PMID: 22127392

10

Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry.

D'Aco K, Underhill L, Rangachari L, Arn P, Cox GF, Giugliani R, Okuyama T, Wijburg F, Kaplan P. D'Aco K, et al. Among authors: giugliani r. Eur J Pediatr. 2012 Jun;171(6):911-9. doi: 10.1007/s00431-011-1644-x. Epub 2012 Jan 11. Eur J Pediatr. 2012. PMID: 22234477 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

574 results

Search Page